ABSTRACT
Introduction South Sudan established an HIV program for the South Sudan People’s Defense Force (SSPDF) in 2006, recognizing the potential national security threat posed by HIV’s impact in post-conflict settings. By 2018, the SSPDF program’s scope had expanded to include three VMMC clinics and four ART service delivery facilities. This qualitative study examined participant feedback on two existing HIV services, ART and VMMC, with the goal of identifying and prioritizing barriers and improving program performance. We used focus group discussions to gather information from male and female participants chosen at random across the four main project sites.
Methods We conducted a cross-sectional qualitative study from March to April 2022 involving 177 people (108 men and 69 women) within fifteen focus group discussions. We collected data on enablers and barriers to HIV service uptake and utilization using a thematic framework approach.
Results Perceived high-quality HIV services in a secure environment, organizational support systems, peer-led mobilization, and transportation facilitation were all identified as HIV service delivery enablers. HIV service delivery was hampered by knowledge gaps, poverty and food insecurity, access issues, a lack of treatment support groups, transportation challenges, social cultural barriers (stigma and discrimination), and the need for permission from commanders.
Conclusions The findings show some overlap in client needs for VMMC and ART services. To increase ART retention and overall HIV service demand, the program will focus on improving the quality of HIV services and tailored client support, as well as addressing barriers resulting from structural and social cultural challenges to increase ART retention and overall HIV service demand.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was work supported, in part, by the Department of Defense HIV/AIDS Prevention Program (DHAPP) grant N00244-21-1-0002. The publication itself was supported by internal funding from RTI International. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, the US Government, or RTI International
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for the study was obtained by RTI’s Institutional Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
N/A relevant data submitted with the manuscript.
